Study: Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis
Virpax Posts Toxicology, Pharmacokinetic Data For Pain Med Epoladerm
EXCLUSIVE: Ampio's Ampion Shows Benefit In Late-Stage Knee Osteoarthritis Study
Sorrento To Start Testing Non-Opioid Candidate In Osteoarthritis-Related Knee Pain
Osteoarthritis Recent News
Can-Fite Stock Gains On Piclidenoson Development Pact For Pets
Galapagos Drops Early Metabolic & Osteoarthritis Programs, Reorganizes R&D Efforts
Pfizer And Eli Lilly's Osteoarthritis Drug Rejected By FDA Panel As Too Risky
Pfizer/Eli Lilly's Tanezumab Safety Profile Fails To Impress FDA Even After 15 Years Of Development Across 41 Trials
Flexion To Test Higher Dose Of FX201 Gene Therapy In Early-Stage Osteoarthritis Study
Zynebra Pharmaceuticals Receives International Patent For Osteoarthritis Treatment With CBD Gel
Sorrento's Knee Pain Medication Found Safe, Effective Based On Early Data
Catalysts Growing Like Weeds For Zynerba Next Quarter
It's High Time For Zynerba Positives: Investors Await 3 Key Mid-Stage Trial Reads On Cannabidiol ZYN002